Want to join the conversation?
$TMO said Life Sciences Solutions' reported and organic revenue grew 11% in 1Q16. Analytical Instruments reported revenue rose 4% in 1Q16 and organic revenue growth was 6%. Specialty Diagnostics total revenue grew 9% and organic revenue growth was 10%. Laboratory Products and Services' 1Q16 reported and organic revenue growth was 14%.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?
After so much controversy and family issues in $VIAB over the recent months, Paramount brings in some good news. News is that they signed a $1 billion deal with Shanghai Film Group and Huahua Media. The material impact to Viacom however is still uncertain.